InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidi…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-27
Interim MD&A - English.pdf
Results 2026-05-27
Interim financial statements/report – English.pdf
Results 2026-05-27
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
News release - English.pdf
News 2026-05-06
Innocan Pharma LPT-CBD is featured in Pain Medicine News
News release - English.pdf
Transactions 2026-04-06 Financing
InnoCan Pharma Corporation Announces Closing of US$200,000 Debenture Offering to Largest Shareholder
Material change report - English.pdf
Transactions 2026-04-06 Financing
Innocan Pharma Announces Closing of Additional Debenture
News release - English.pdf
Transactions 2026-03-31 Financing
Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
News release - English.pdf
Results 2026-03-31
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
News release - English.pdf
Results 2026-03-30
Annual MD&A - English.pdf
Results 2026-03-30
Audited annual financial statements – English.pdf
Transactions 2026-03-17 Financing
InnoCan Pharma Corporation Closes US$450,000 Debenture Offering to Largest Shareholder
Material change report - English.pdf
Transactions 2026-03-16 Financing
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
News release - English.pdf
Transactions 2026-03-11 Financing
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
News release - English.pdf
News 2026-02-27
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
News release - English.pdf
Results 2026-02-09
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
News release - English.pdf
Results 2025-12-17
Innocan Pharma announces promising results of LPT-CBD administered to Göttingen Minipigs, a well-known drug toxicology model
News release - English.pdf
Transactions 2025-12-11 Financing
Innocan Pharma Corporation Files Amended Registration Statement on Form F-1 with SEC for Proposed Public Offering of Units
Material change report - English.pdf
News 2025-12-10
Other.pdf
Transactions 2025-12-10 Financing
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
News release - English.pdf
Results 2025-11-27
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
News release - English.pdf
Results 2025-11-26 Financials
Interim MD&A - English.pdf
Results 2025-11-26 Financials
Interim financial statements/report – English.pdf
News 2025-11-24
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
News release - English.pdf
News 2025-10-24
News release - English.pdf
News 2025-10-15
News release - English.pdf
News 2025-09-18
News release - English.pdf
News 2025-09-15
News release - English.pdf
News 2025-09-05
Material change report - English.pdf
News 2025-08-29
News release - English.pdf
Results 2025-08-27 Financials
Interim financial statements/report – English.pdf
Results 2025-08-27 Financials
Interim MD&A - English.pdf
News 2025-08-27
News release - English.pdf
News 2025-08-22
News release - English.pdf
News 2025-07-31
Material change report - English.pdf
News 2025-07-23
News release - English.pdf
News 2025-07-03
News release - English.pdf
News 2025-06-20
News release - English.pdf
News 2025-06-13
News release - English.pdf
News 2025-06-06
Other.pdf